Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Mol Cell Proteomics ; 21(3): 100197, 2022 03.
Article in English | MEDLINE | ID: mdl-35033677

ABSTRACT

The gut microbiota plays an important yet incompletely understood role in the induction and propagation of ulcerative colitis (UC). Organism-level efforts to identify UC-associated microbes have revealed the importance of community structure, but less is known about the molecular effectors of disease. We performed 16S rRNA gene sequencing in parallel with label-free data-dependent LC-MS/MS proteomics to characterize the stool microbiomes of healthy (n = 8) and UC (n = 10) patients. Comparisons of taxonomic composition between techniques revealed major differences in community structure partially attributable to the additional detection of host, fungal, viral, and food peptides by metaproteomics. Differential expression analysis of metaproteomic data identified 176 significantly enriched protein groups between healthy and UC patients. Gene ontology analysis revealed several enriched functions with serine-type endopeptidase activity overrepresented in UC patients. Using a biotinylated fluorophosphonate probe and streptavidin-based enrichment, we show that serine endopeptidases are active in patient fecal samples and that additional putative serine hydrolases are detectable by this approach compared with unenriched profiling. Finally, as metaproteomic databases expand, they are expected to asymptotically approach completeness. Using ComPIL and de novo peptide sequencing, we estimate the size of the probable peptide space unidentified ("dark peptidome") by our large database approach to establish a rough benchmark for database sufficiency. Despite high variability inherent in patient samples, our analysis yielded a catalog of differentially enriched proteins between healthy and UC fecal proteomes. This catalog provides a clinically relevant jumping-off point for further molecular-level studies aimed at identifying the microbial underpinnings of UC.


Subject(s)
Colitis, Ulcerative , Microbiota , Chromatography, Liquid , Colitis, Ulcerative/diagnosis , Colitis, Ulcerative/microbiology , Endopeptidases , Feces/microbiology , Humans , RNA, Ribosomal, 16S/genetics , Serine , Tandem Mass Spectrometry
2.
ACS Chem Biol ; 15(2): 575-586, 2020 02 21.
Article in English | MEDLINE | ID: mdl-31927936

ABSTRACT

Caspases are a critical class of proteases involved in regulating programmed cell death and other biological processes. Selective inhibitors of individual caspases, however, are lacking, due in large part to the high structural similarity found in the active sites of these enzymes. We recently discovered a small-molecule inhibitor, 63-R, that covalently binds the zymogen, or inactive precursor (pro-form), of caspase-8, but not other caspases, pointing to an untapped potential of procaspases as targets for chemical probes. Realizing this goal would benefit from a structural understanding of how small molecules bind to and inhibit caspase zymogens. There have, however, been very few reported procaspase structures. Here, we employ X-ray crystallography to elucidate a procaspase-8 crystal structure in complex with 63-R, which reveals large conformational changes in active-site loops that accommodate the intramolecular cleavage events required for protease activation. Combining these structural insights with molecular modeling and mutagenesis-based biochemical assays, we elucidate key interactions required for 63-R inhibition of procaspase-8. Our findings inform the mechanism of caspase activation and its disruption by small molecules and, more generally, have implications for the development of small molecule inhibitors and/or activators that target alternative (e.g., inactive precursor) protein states to ultimately expand the druggable proteome.


Subject(s)
Acetamides/metabolism , Caspase 8/metabolism , Caspase Inhibitors/metabolism , Enzyme Precursors/antagonists & inhibitors , Enzyme Precursors/metabolism , Piperidines/metabolism , Caspase 8/chemistry , Caspase 8/genetics , Catalytic Domain/drug effects , Crystallography, X-Ray , Enzyme Precursors/chemistry , Enzyme Precursors/genetics , Humans , Molecular Docking Simulation , Mutagenesis, Site-Directed , Mutation , Protein Binding , Protein Conformation/drug effects
3.
ACS Chem Biol ; 13(9): 2513-2521, 2018 09 21.
Article in English | MEDLINE | ID: mdl-30085657

ABSTRACT

Proteases within the C1B hydrolase family are encoded by many organisms. We subjected a putative C1B-like cysteine protease secreted by the human gut commensal Parabacteroides distasonis to mass spectrometry-based substrate profiling to find preferred peptide substrates. The P. distasonis protease, which we termed Pd_dinase, has a sequential diaminopeptidase activity with strong specificity for N-terminal glycine residues. Using the substrate sequence information, we verified the importance of the P2 glycine residue with a panel of fluorogenic substrates and calculated kcat and KM for the dipeptide glycine-arginine-AMC. A potent and irreversible dipeptide inhibitor with a C-terminal acyloxymethyl ketone warhead, glycine-arginine- AOMK, was then synthesized and demonstrated that the Pd_dinase active site requires a free N-terminal amine for potent and rapid inhibition. We next determined the homohexameric Pd_dinase structure in complex with glycine-arginine- AOMK and uncovered unexpected active site features that govern the strict substrate preferences and differentiate this protease from members of the C1B and broader papain-like C1 protease families. We finally showed that Pd_dinase hydrolyzes several human antimicrobial peptides and therefore posit that this P. distasonis enzyme may be secreted into the extracellular milieu to assist in gut colonization by inactivation of host antimicrobial peptides.


Subject(s)
Aminopeptidases/metabolism , Antimicrobial Cationic Peptides/metabolism , Bacteroides/enzymology , Gastrointestinal Microbiome , Glycine/metabolism , Aminopeptidases/chemistry , Antimicrobial Cationic Peptides/chemistry , Bacteroides/chemistry , Bacteroides/metabolism , Glycine/chemistry , Humans , Models, Molecular , Protein Multimerization , Proteolysis , Substrate Specificity
SELECTION OF CITATIONS
SEARCH DETAIL